These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3243811)

  • 1. Thin-layer chromatographic study of the metabolites of erythromycins in the Wistar rat.
    Kibwage IO; Roets E; Verbruggen A; Hoogmartens J; Vanderhaeghe H
    J Chromatogr; 1988 Dec; 434(1):177-86. PubMed ID: 3243811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of erythromycin and related substances by high-performance liquid chromatography on poly(styrene-divinylbenzene) packing materials.
    Kibwage IO; Roets E; Hoogmartens J; Vanderhaeghe H
    J Chromatogr; 1985 Aug; 330(2):275-86. PubMed ID: 4066823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimization of the separation of erythromycin and related substances by high-performance liquid chromatography.
    Cachet T; Kibwage IO; Roets E; Hoogmartens J; Vanderhaeghe H
    J Chromatogr; 1987 Nov; 409():91-100. PubMed ID: 3693497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of impurities in erythromycin by liquid chromatography-mass spectrometric detection.
    Kumar Chitneni S; Govaerts C; Adams E; Van Schepdael A; Hoogmartens J
    J Chromatogr A; 2004 Nov; 1056(1-2):111-20. PubMed ID: 15595540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-Didemethyl-n-propionyl-6,9;9, 12-erythromycin A-spiroketal, a new metabolite of erythromycin ethyl succinate in man.
    Majer J; Stanaszek RS; Mueller SL; Marti G
    Drug Metab Dispos; 1978; 6(6):673-6. PubMed ID: 33030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition of drug oxidation by anhydroerythromycin, an acid degradation product of erythromycin.
    Stupans I; Sansom LN
    Biochem Pharmacol; 1991 Nov; 42(11):2085-90. PubMed ID: 1958226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demethylation of erythromycins by rabbit tissues in vitro.
    Mao JC; Tardrew PL
    Biochem Pharmacol; 1965 Jul; 14(7):1049-58. PubMed ID: 5854735
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of in vivo treatment with a new fluorinated macrolide (P-0501A) and other erythromycins on drug clearance and hepatic functions in perfused rat liver.
    Villa P; Corti F; Guaitani A; Bartosek I; Casacci F; De Marchi F; Pacei E
    J Antibiot (Tokyo); 1986 Jun; 39(6):839-45. PubMed ID: 3733532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical modification of erythromycins. IX. Selective methylation at the C-6 hydroxyl group of erythromycin A oxime derivatives and preparation of clarithromycin.
    Watanabe Y; Morimoto S; Adachi T; Kashimura M; Asaka T
    J Antibiot (Tokyo); 1993 Apr; 46(4):647-60. PubMed ID: 8501007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microanalysis of free and conjugated bile acids by thin-layer chromatography and in situ spectrofluorimetry.
    Van den Ende A; Rädecker CE; Mairuhu WM
    Anal Biochem; 1983 Oct; 134(1):153-62. PubMed ID: 6660485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial degradation of erythromycins A and B.
    Flickinger MC; Perlman D
    J Antibiot (Tokyo); 1975 Apr; 28(4):307-11. PubMed ID: 1150530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the stereochemistry of anhydroerythromycin A, the principal degradation product of the antibiotic erythromycin A.
    Hassanzadeh A; Helliwell M; Barber J
    Org Biomol Chem; 2006 Mar; 4(6):1014-9. PubMed ID: 16525545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biogenetic relationship of the erythromycins and the lactone of erythromycin B.
    Spizek J; Chick M; Corcoran JW
    Antimicrob Agents Chemother (Bethesda); 1965; 5():138-43. PubMed ID: 5883418
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of novel erythromycin derivatives in mother liquor concentrates of Streptomyces erythraeus.
    Kibwage IO; Janssen G; Busson R; Hoogmartens J; Vanderhaeghe H; Verbist L
    J Antibiot (Tokyo); 1987 Jan; 40(1):1-6. PubMed ID: 3558111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical modification of erythromycins. IV. Synthesis and biological properties of 6-O-methylerythromycin B.
    Morimoto S; Adachi T; Misawa Y; Nagate T; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1990 May; 43(5):544-9. PubMed ID: 2358406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and disposition of clarithromycin in man.
    Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
    Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical modification of erythromycins. II. Synthesis and antibacterial activity of O-alkyl derivatives of erythromycin A.
    Morimoto S; Misawa Y; Adachi T; Nagate T; Watanabe Y; Omura S
    J Antibiot (Tokyo); 1990 Mar; 43(3):286-94. PubMed ID: 2324013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythromycin series. IV. Thin-layer chromatography of erythromycin, erythromycin oxime, erythromyclamine and their acyl derivatives.
    Kobrehel G; Tamburasev Z; Djokić S
    J Chromatogr; 1977 Mar; 133(2):415-9. PubMed ID: 838822
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative liver toxicity of various erythromycin derivatives in animals.
    Viluksela M; Hanhijärvi H; Husband RF; Kosma VM; Collan Y; Männistö PT
    J Antimicrob Chemother; 1988 Jun; 21 Suppl D():9-27. PubMed ID: 3391880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the potential of erythromycin and derivatives as chiral selector in capillary electrophoresis.
    Thanh Ha PT; Van Schepdael A; Roets E; Hoogmartens J
    J Pharm Biomed Anal; 2004 Mar; 34(5):861-70. PubMed ID: 15019020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.